BeOne Medicines Ltd.
ONC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 14 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $9.93B in total; no superinvestor holds it.
Other share classesBEIGF
13F holders, Q2 2024
Institutional positions in BeOne Medicines Ltd. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 200
- −4 vs. Q1 2024
- Shares held
- 46.8M
- +352.0K (+0.8%) vs. Q1 2024
- Total value
- $6.68B
- −$584.2M (−8.0%) vs. Q1 2024
- New holders
- 20
- 72 more added
- Sold out
- 24
- 66 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 283 | $9.93B |
| Q1 2026 | 282 | $10.3B |
| Q4 2025 | 288 | $10.3B |
| Q3 2025 | 266 | $11.2B |
| Q2 2025 | 245 | $8.34B |
| Q1 2025 | 268 | $11.6B |
| Q4 2024 | 229 | $8.07B |
| Q3 2024 | 228 | $10.4B |
| Q2 2024 | 200 | $6.68B |
| Q1 2024 | 205 | $7.27B |
| Q4 2023 | 204 | $8.11B |
| Q3 2023 | 201 | $8.46B |
| Q2 2023 | 209 | $8.39B |
| Q1 2023 | 220 | $10.3B |
| Q4 2022 | 214 | $10.9B |
| Q3 2022 | 223 | $7.22B |
| Q2 2022 | 235 | $8.67B |
| Q1 2022 | 238 | $10.4B |
| Q4 2021 | 263 | $15.0B |
| Q3 2021 | 255 | $20.4B |
| Q2 2021 | 268 | $19.1B |
| Q1 2021 | 253 | $19.5B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding BeOne Medicines Ltd.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| XY Capital Ltd | 0 | $0 | 0.00% | −29,616−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −18,954−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Polymer Capital Management (HK) LTD | 0 | $0 | 0.00% | −9,500−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −8,043−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −5,299−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −5,120−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −3,439−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2,533−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −1,445−100.0% | Sold out |
| Qtron Investments LLC | 0 | $0 | 0.00% | −1,378−100.0% | Sold out |
| Envestnet Portfolio Solutions, Inc. | 0 | $0 | 0.00% | −1,339−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −333−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Colonial Trust Advisors | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Pinpoint Asset Management Ltd | 0 | $0 | 0.00% | −5,300−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |